Search Options Stock News and Analysis from Schaeffer's

3 Biotech Stocks to Watch Heading Into 2023

https://www.schaeffersresearch.com/content/options/2022/12/29/3-biotech-stocks-to-watch-heading-into-2023

12/29/2022 2:49 PM

Pharma and biotech stocks are enjoying tailwinds as part of the broad market rally today. Biogen Inc (NASDAQ:BIIB), Crispr Therapeutics AG (NASDAQ:CRSP), and also Vertex Pharmaceuticals Incorporated ...

Biotech Stock Could Be Headed Toward New Record Highs

https://www.schaeffersresearch.com/content/analysis/2020/10/13/biotech-stock-could-be-headed-toward-new-record-highs

10/13/2020 3:34 PM

The shares of Crispr Therapeutics (NASDAQ:CRSP) are up 0.8% to trade at $100.24 at last check. And while the pharmaceutical stock has cooled off from its all-time-high of $105.12 on Aug. 19, it has s...

Strong First Week of August Marred by Stimulus, China Tensions

https://www.schaeffersresearch.com/content/news/2020/08/07/strong-first-week-of-august-marred-by-stimulus-china-tensions

8/7/2020 1:28 PM

Volatile sentiment surrounding the stalled second stimulus bill in congress permeated through the market this week, as investors listened for cues as to whether the stiff negotiations would soon be...

Bullish Signal Could Mean New Heights for Gene Therapy Stock

https://www.schaeffersresearch.com/content/options/2020/08/05/bullish-signal-could-mean-new-heights-for-gene-therapy-stock

8/5/2020 2:52 PM

The shares of Crispr Therapeutics AG ( NASDAQ: CRSP) are down 1.2% to trade at $93.47 this afternoon, though the stock still enjoys a 97.8% year-over-year lead, with support from its the 30-day moving...

2 Drug Stocks Climbing on FDA News

https://www.schaeffersresearch.com/content/news/2019/04/16/2-drug-stocks-climbing-on-fda-news

4/16/2019 10:24 AM

Two pharma names are scaling the Nasdaq this morning, thanks to favorable rulings from the Food and Drug Administration (FDA). First up is CRISPR Therapeutics AG (NASDAQ:CRSP), up 9.1% to trade at $40...

PEOPLE ALSO SEARCH FOR